131 related articles for article (PubMed ID: 25712539)
1. Recurrent genomic rearrangements in primary testicular lymphoma.
Twa DD; Mottok A; Chan FC; Ben-Neriah S; Woolcock BW; Tan KL; Mungall AJ; McDonald H; Zhao Y; Lim RS; Nelson BH; Milne K; Shah SP; Morin RD; Marra MA; Scott DW; Gascoyne RD; Steidl C
J Pathol; 2015 Jun; 236(2):136-41. PubMed ID: 25712539
[TBL] [Abstract][Full Text] [Related]
2. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
Steidl C; Shah SP; Woolcock BW; Rui L; Kawahara M; Farinha P; Johnson NA; Zhao Y; Telenius A; Neriah SB; McPherson A; Meissner B; Okoye UC; Diepstra A; van den Berg A; Sun M; Leung G; Jones SJ; Connors JM; Huntsman DG; Savage KJ; Rimsza LM; Horsman DE; Staudt LM; Steidl U; Marra MA; Gascoyne RD
Nature; 2011 Mar; 471(7338):377-81. PubMed ID: 21368758
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas.
Chong LC; Twa DD; Mottok A; Ben-Neriah S; Woolcock BW; Zhao Y; Savage KJ; Marra MA; Scott DW; Gascoyne RD; Morin RD; Mungall AJ; Steidl C
Blood; 2016 Sep; 128(9):1206-13. PubMed ID: 27268263
[TBL] [Abstract][Full Text] [Related]
4. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations.
Wlodarska I; Veyt E; De Paepe P; Vandenberghe P; Nooijen P; Theate I; Michaux L; Sagaert X; Marynen P; Hagemeijer A; De Wolf-Peeters C
Leukemia; 2005 Aug; 19(8):1299-305. PubMed ID: 15944719
[TBL] [Abstract][Full Text] [Related]
5. Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.
Twa DD; Chan FC; Ben-Neriah S; Woolcock BW; Mottok A; Tan KL; Slack GW; Gunawardana J; Lim RS; McPherson AW; Kridel R; Telenius A; Scott DW; Savage KJ; Shah SP; Gascoyne RD; Steidl C
Blood; 2014 Mar; 123(13):2062-5. PubMed ID: 24497532
[TBL] [Abstract][Full Text] [Related]
6. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
7. t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
Fenton JA; Schuuring E; Barrans SL; Banham AH; Rollinson SJ; Morgan GJ; Jack AS; van Krieken JH; Kluin PM
Genes Chromosomes Cancer; 2006 Feb; 45(2):164-8. PubMed ID: 16252263
[TBL] [Abstract][Full Text] [Related]
8. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.
Rouhigharabaei L; Finalet Ferreiro J; Tousseyn T; van der Krogt JA; Put N; Haralambieva E; Graux C; Maes B; Vicente C; Vandenberghe P; Cools J; Wlodarska I
PLoS One; 2014; 9(1):e85851. PubMed ID: 24416450
[TBL] [Abstract][Full Text] [Related]
9. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
Goatly A; Bacon CM; Nakamura S; Ye H; Kim I; Brown PJ; Ruskoné-Fourmestraux A; Cervera P; Streubel B; Banham AH; Du MQ
Mod Pathol; 2008 Jul; 21(7):902-11. PubMed ID: 18487996
[TBL] [Abstract][Full Text] [Related]
10. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A
Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129
[TBL] [Abstract][Full Text] [Related]
11. FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
[TBL] [Abstract][Full Text] [Related]
12. Structural genomic alterations in primary mediastinal large B-cell lymphoma.
Twa DD; Steidl C
Leuk Lymphoma; 2015; 56(8):2239-50. PubMed ID: 25393674
[TBL] [Abstract][Full Text] [Related]
13. Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
Barrans SL; Fenton JA; Ventura R; Smith A; Banham AH; Jack AS
Haematologica; 2007 Jun; 92(6):863-4. PubMed ID: 17550867
[TBL] [Abstract][Full Text] [Related]
14. Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression.
Mottok A; Woolcock B; Chan FC; Tong KM; Chong L; Farinha P; Telenius A; Chavez E; Ramchandani S; Drake M; Boyle M; Ben-Neriah S; Scott DW; Rimsza LM; Siebert R; Gascoyne RD; Steidl C
Cell Rep; 2015 Nov; 13(7):1418-1431. PubMed ID: 26549456
[TBL] [Abstract][Full Text] [Related]
15. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.
Howitt BE; Sun HH; Roemer MG; Kelley A; Chapuy B; Aviki E; Pak C; Connelly C; Gjini E; Shi Y; Lee L; Viswanathan A; Horowitz N; Neuberg D; Crum CP; Lindeman NL; Kuo F; Ligon AH; Freeman GJ; Hodi FS; Shipp MA; Rodig SJ
JAMA Oncol; 2016 Apr; 2(4):518-22. PubMed ID: 26913631
[TBL] [Abstract][Full Text] [Related]
16. Diffuse large B-cell lymphoma with TEL/ETV6 translocation.
Sevilla DW; Nandula SV; Colovai AI; Alexander S; Murty VV; Alobeid B; Bhagat G
Hum Pathol; 2009 Apr; 40(4):588-93. PubMed ID: 18992913
[TBL] [Abstract][Full Text] [Related]
17. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.
Van Roosbroeck K; Ferreiro JF; Tousseyn T; van der Krogt JA; Michaux L; Pienkowska-Grela B; Theate I; De Paepe P; Dierickx D; Doyen C; Put N; Cools J; Vandenberghe P; Wlodarska I
Genes Chromosomes Cancer; 2016 May; 55(5):428-41. PubMed ID: 26850007
[TBL] [Abstract][Full Text] [Related]
19. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
20. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
Twa DDW; Mottok A; Savage KJ; Steidl C
Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
